Trial Profile
Effectiveness of arbiraterone acetate in patients with castration-resistant prostate cancer (CRPC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Apr 2018
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Apr 2018 New trial record